Fludarabine/full dose i.v. busulfan conditioning regimen in allogeneic PBSC transplantation for high risk patients

被引：0
|
作者：
Chunduri, S. [1 ]
Dobogai, L. C. [1 ]
Peace, D. [1 ]
Saunthararajah, Y. [1 ]
Quigley, J. [1 ]
Chen, Y. -H. [1 ]
Boccuni, P. [1 ]
Hoffman, R. [1 ]
Mahmud, N. [1 ]
Beri, R. [1 ]
Hurter, E. [1 ]
Rondelli, D. [1 ]
机构：
[1] Univ Illinois, Hematol Oncol Sect, Chicago, IL USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2007年 / 13卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2006.12.235
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
230
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [41] A PHASE I STUDY OF CLOFARABINE PLUS HIGH DOSE MELPHALAN AS A CONDITIONING REGIMEN FOR ALLOGENEIC TRANSPLANTATION
    Kirschbaum, M. H.
    Stein, A. S.
    Nakamura, R.
    Auayporn, N.
    Popplewell, L.
    Delioukina, M.
    Chen, R.
    Snyder, D.
    Conrad, J.
    Frankel, P.
    Forman, S. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S278 - S278
  • [42] Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high-risk patients
    Baronciani, Donatella
    Rambaldi, Alessandro
    Iori, Anna Paola
    Di Bartolomeo, Paolo
    Pilo, Federica
    Pettinau, Martina
    Depau, Cristina
    Mico, Caterina
    Santarone, Stella
    Angelucci, Emanuele
    AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (09) : 717 - 720
  • [43] Comparison of BuCy (Busulfan plus Cyclophosphamide) Versus FluBu4 (Fludarabine plus Busulfan) As a Conditioning Regimen for Allogeneic Stem Cell Transplantation
    Park, Silvia
    Hong, Jung Yong
    Choi, Moon Ki
    Kim, Young Saing
    Lee, Ji Yun
    Lim, Sung Hee
    Jung, Chul Won
    Jang, Jun Ho
    Kim, Kihyun
    BLOOD, 2012, 120 (21)
  • [44] Use of fludarabine and low dose intravenous busulfan as conditioning regimen in patients with Fanconi anemia and myelodysplastic syndromes
    George, B.
    Poonkuzhali, B.
    Pavai, E. M.
    Mathews, V.
    Srivastava, A.
    LEUKEMIA RESEARCH, 2013, 37 : S121 - S121
  • [45] Fludarabine and treosulfan conditioning for allogeneic stem cell transplantation; a dose-intense regimen with limited toxicity
    Shimoni, A.
    Rand, A.
    Shem-Tov, N.
    Volchek, Y.
    Yerushalmi, R.
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S287 - S287
  • [46] Conditioning regimen with a 75% dose of standard busulfan/cyclophosphamide plus fludarabine before cord blood transplantation in older patients with AML and MDS
    Ohta, Takanori
    Sugio, Yasuhiro
    Imanaga, Hiroshi
    Oku, Seidou
    Ohno, Yuju
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (03) : 347 - 354
  • [47] Conditioning regimen with a 75% dose of standard busulfan/cyclophosphamide plus fludarabine before cord blood transplantation in older patients with AML and MDS
    Takanori Ohta
    Yasuhiro Sugio
    Hiroshi Imanaga
    Seidou Oku
    Yuju Ohno
    International Journal of Hematology, 2019, 110 : 347 - 354
  • [48] Reduced Intensity Conditioning (Fludarabine and Busulfan) for Allogeneic Hematopoietic Cell Transplantation in Patients with Severe Aplastic Anemia
    Chilkulwar, Abhishek
    Sadashiv, Santhosh
    Khan, Cyrus
    Fazal, Salman
    Mewawalla, Prerna
    Kaminsky, Anna
    Berteotti, Gina
    Padhi, Parikshit
    Lister, John
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S264 - S265
  • [49] Busulfan area-under-the-curve finding study within a busulfan/fludarabine (BuFlu) conditioning regimen before allogeneic hematopoietic cell Transplantation (HCT).
    Field, Teresa
    Perkins, Janelle
    Alsina, Melissa
    Ayala, Ernesto
    Fancher, Karen
    Fernandez, Hugo F.
    Garrett, Dawn
    Janssen, William
    Kharfan-Dabaja, Mohamed
    Perez, Lia
    Sullivan, Daniel
    Tate, Cheryl
    Anasetti, Claudio
    BLOOD, 2006, 108 (11) : 832A - 832A
  • [50] Fludarabin and Busulfan as a conditioning regimen for allogeneic peripheral blood stem cells transplantation in leukemic patients
    Ghavamzadeh, A
    Iravani, M
    Evazi, M
    Shamshiri, A
    Mousavi, A
    Bahar, B
    Gholibeikian, S
    Chardoli, B
    Jahani, M
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 35 - 35
12345